[caption id="attachment_1238247" align="aligncenter" width="1456"] A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications...
Keep Reading →
June 29 - News
As we speak in mid-2025, the U.S. equity market continues to show modest gains. The NASDAQ exchange is up 4.44% YTD, while the broader market is advancing by 4.41% YTD.
Keep Reading →
June 26 - Hedge Funds, News
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential.
Keep Reading →
June 11 - News
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Keep Reading →
June 11 - Hedge Funds, News
On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.
Keep Reading →
June 3 - News
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a returning positive sentiment.
Keep Reading →
May 13 - Hedge Funds, News
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2025 Earnings Call Transcript May 1, 2025Alnylam Pharmaceuticals, Inc. beats earnings expectations.
Keep Reading →
May 3 - News, Transcripts
The stock market has been on a rollercoaster ride for the past few weeks as the sentiment has quickly shifted from post-election bullishness to being priced in for a slow-down...
Keep Reading →
April 14 - Hedge Funds, News
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Keep Reading →
April 8 - Hedge Funds, News
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Keep Reading →
February 24 - Hedge Funds, News
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2024 Earnings Call Transcript February 13, 2025Alnylam Pharmaceuticals, Inc. misses on earnings expectations.
Keep Reading →
February 17 - News, Transcripts
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Keep Reading →
December 23 - Hedge Funds, News
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Keep Reading →
November 30 - Hedge Funds, News
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2024 Earnings Call Transcript October 31, 2024Alnylam Pharmaceuticals, Inc. beats earnings expectations.
Keep Reading →
November 1 - News, Transcripts
Fidelity Investments, an investment management company, released its “Fidelity Growth Strategies Fund” second quarter 2024 investor letter.
Keep Reading →
October 1 - Hedge Fund Investor Letters, News
If you're putting money in the stock market, it's more likely than not that growth is the thing that's on your mind.
Keep Reading →
September 11 - Hedge Funds, News
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second quarter 2024 investor letter.
Keep Reading →
August 21 - Hedge Fund Investor Letters, News
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q2 2024 Earnings Call Transcript August 1, 2024Alnylam Pharmaceuticals, Inc. beats earnings expectations.
Keep Reading →
August 2 - News, Transcripts
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.
Keep Reading →
May 3 - News, Transcripts
In this article, we discuss the 5 most promising stocks to buy before they take off.
Keep Reading →
April 29 - News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.1, expectations were $-1.2.
Keep Reading →
February 16 - News, Transcripts
In this article, we will take a look at the 5 high growth healthcare stocks to buy.
Keep Reading →
December 26 - Hedge Funds, News
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
Keep Reading →
December 19 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call.
Keep Reading →
November 4 - News, Transcripts
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
Keep Reading →
September 20 - Hedge Funds, News
US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further taming.
Keep Reading →
August 27 - Hedge Funds, News
In this article, we discuss 15 worst performing biotech stocks in 2023.
Keep Reading →
August 8 - Hedge Funds, News, Stock Analysis
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q2 2023 Earnings Conference Call.
Keep Reading →
August 4 - News, Transcripts
Operator: Thank you for standing by and welcome to the Alnylam Pharmaceuticals First Quarter 2023 Financial Results Conference Call.
Keep Reading →
May 9 - News, Transcripts
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is one of the high growth healthcare companies that is working on treatments for neuropsychiatric and neurologic disorders.
Keep Reading →
February 26 - Hedge Funds, News
Operator: Thank you for standing by and welcome to the Alnylam Pharmaceuticals Fourth Quarter 2022 Financial Results Conference Call.
Keep Reading →
February 25 - News, Transcripts
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” fourth quarter 2022 investor letter.
Keep Reading →
February 23 - Hedge Fund Investor Letters, News
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Keep Reading →
December 5 - Hedge Funds, News
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.
Keep Reading →
October 31 - Hedge Funds, News
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
October 18 - Hedge Fund Investor Letters, News
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.
Keep Reading →
August 2 - Hedge Funds, News
In this article, we discuss the 10 stocks to buy before the next pandemic.
Keep Reading →
June 7 - Hedge Funds, News
Evotec SE (NYSE:EVO) is a German drug discovery, pharmaceutical, and biotechnology company that produces drug candidates for diabetes, fibrosis, infectious diseases, CNS diseases...
Keep Reading →
May 30 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
February 4 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
December 8 - Hedge Funds, News
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Keep Reading →
December 7 - Hedge Funds, News
In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Keep Reading →
December 4 - Hedge Funds, News
In this article, we discuss the 10 stocks that analysts are increasing price targets of.
Keep Reading →
October 29 - Hedge Funds, News
In this article, we will take a look at the 11 best genomic stocks to buy now.
Keep Reading →
October 19 - Hedge Funds, News
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
October 18 - Hedge Funds, News
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Keep Reading →
September 20 - Hedge Funds, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Keep Reading →
July 6 - Hedge Funds, News
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now.
Keep Reading →
March 29 - Hedge Funds, News
